These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy. Jo SD; Ku SH; Won YY; Kim SH; Kwon IC Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785 [TBL] [Abstract][Full Text] [Related]
5. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives. Ma Y; Huang J; Song S; Chen H; Zhang Z Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247 [TBL] [Abstract][Full Text] [Related]
6. Peptide-modulated self-assembly as a versatile strategy for tumor supramolecular nanotheranostics. Li S; Zou Q; Xing R; Govindaraju T; Fakhrullin R; Yan X Theranostics; 2019; 9(11):3249-3261. PubMed ID: 31244952 [TBL] [Abstract][Full Text] [Related]
7. Artificial Molecular Machines in Nanotheranostics. Yu G; Yung BC; Zhou Z; Mao Z; Chen X ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247 [TBL] [Abstract][Full Text] [Related]
8. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice? Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491 [TBL] [Abstract][Full Text] [Related]
9. Bioinspired approaches for cancer nanotheranostics. Evangelopoulos M; Tasciotti E Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435 [No Abstract] [Full Text] [Related]
10. Nanomaterials with Supramolecular Assembly Based on AIE Luminogens for Theranostic Applications. Song N; Zhang Z; Liu P; Yang YW; Wang L; Wang D; Tang BZ Adv Mater; 2020 Dec; 32(49):e2004208. PubMed ID: 33150632 [TBL] [Abstract][Full Text] [Related]
11. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy. Muthu MS; Mehata AK; Viswanadh MK Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815 [No Abstract] [Full Text] [Related]
12. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Pan X; Wang H; Wang S; Sun X; Wang L; Wang W; Shen H; Liu H Sci China Life Sci; 2018 Apr; 61(4):415-426. PubMed ID: 29666990 [TBL] [Abstract][Full Text] [Related]
13. Two-Dimensional Nanomaterials for Cancer Nanotheranostics. Chen Y; Wu Y; Sun B; Liu S; Liu H Small; 2017 Mar; 13(10):. PubMed ID: 28075057 [TBL] [Abstract][Full Text] [Related]
14. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine? Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597 [TBL] [Abstract][Full Text] [Related]
15. Theranostic barcoded nanoparticles for personalized cancer medicine. Yaari Z; da Silva D; Zinger A; Goldman E; Kajal A; Tshuva R; Barak E; Dahan N; Hershkovitz D; Goldfeder M; Roitman JS; Schroeder A Nat Commun; 2016 Nov; 7():13325. PubMed ID: 27830705 [TBL] [Abstract][Full Text] [Related]
17. 2D Nanomaterials for Cancer Theranostic Applications. Cheng L; Wang X; Gong F; Liu T; Liu Z Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752 [TBL] [Abstract][Full Text] [Related]
18. Supramolecular Polysaccharide Nanotheranostics that Inhibit Cancer Cells Growth and Monitor Targeted Therapy Response. Deshpande N; Ramesh A; Nandi D; Nguyen A; Brouillard A; Kulkarni A Nanotheranostics; 2020; 4(3):156-172. PubMed ID: 32483521 [TBL] [Abstract][Full Text] [Related]
19. Theranostics - a sure cure for cancer after 100 years? Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648 [TBL] [Abstract][Full Text] [Related]